Technological Options for the Production of Health-Promoting Proteins and Peptides Derived from Milk and Colostrum
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Milk proteins are known to exert a wide range of nutritional, functional and biological activities. Apart from being a balanced source of valuable amino acids, milk proteins contribute to the consistency and sensory properties of various dairy products. Furthermore, many milk proteins possess specific biological properties which make them potential ingredients of health-promoting foods. These properties are attributed to both native protein molecules and to physiologically active peptides encrypted in the protein molecules. Considerable progress has been made over the last twenty years in technologies aimed at separation, fractionation and isolation in a purified form of many interesting proteins occurring in bovine colostrum and milk. Industrial-scale methods have been developed for native whey proteins such as immunoglobulins, lactoferrin, lactoperoxidase, alpha-lactalbumin and beta-lactoglobulin. Their large-scale manufacture and commercial exploitation is still limited although validated research data about their physiological health benefits is rapidly accumulating. Promising product concepts and novel fields of use have emerged recently, and some of these molecules have already found commercial applications. The same applies to bioactive peptides derived from different milk proteins. Active peptides can be liberated during gastrointestinal digestion or milk fermentation with proteolytic enzymes. Such peptides may exert a number of physiological effects in vivo on the gastrointestinal, cardiovascular, endocrine, immune, nervous and other body systems. However, at present the industrial-scale production of such peptides is limited by a lack of suitable technologies. On the other hand, a number of bioactive peptides have been identified in fermented dairy products, and there are already a few commercial dairy products enriched with blood pressure-reducing milk protein peptides. There is a need to develop methods to optimise the activity of bioactive peptides in food systems and to enable their optimum utilisation in the body. This review highlights existing modern technologies applicable for the isolation of bioactive native proteins and peptides derived from bovine colostrum, milk and cheese whey, and discusses aspects of their current and potential applications for human nutrition and promotion of human health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioactive milk peptides: a prospectus.
Clare, D. A., & Swaisgood, H. E. (2000) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(00)74983-6 · Cited by 718 · cited 1×
“A great number of bioactive peptides have been identified, exhibiting various activities including antioxidative, anti-hypertensive, antimicrobial, immunomodulatory, opioid or mineral-carrying activity [16-22].”
BackgroundPeptidases and amino acid catabolism in lactic acid bacteria
Christensen, J. E., Dudley, E. G., Pederson, J. A., & Steele, J. L. (1999) · Antonie van Leeuwenhoek · doi:10.1023/a:1002001919720 · Cited by 630 · cited 1×
“This system consists of a cell wall -bound proteinase and a number of distinct intracellular peptidases, including endopeptidases, aminopeptidases, tripeptidases and dipeptidases [97].”
BackgroundYamamoto, N., Akino, A., & Takano, T. (1994) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(94)77026-0 · Cited by 418
Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects.
H., M., & J., F. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454847 · Cited by 407 · cited 1×
“For example, ACE-inhibitory peptides and calciumbinding phosphopeptides (CPPs) are most commonly produced by trypsin [104, 123-126] Moreover, ACE-inhibitory peptides have recently been identified in tryptic hydrolysates of bovine s2-casein [127] and in bovine, ovine and caprine -casein macropeptides [128].”
BackgroundYamamoto, N., Maeno, M., & Takano, T. (1999) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(99)75364-6 · Cited by 266 · cited 3×
“[106] identified an ACE-inhibitory dipeptide (Tyr-Pro) from a yoghurt-like product fermented with Lb.”
BackgroundLeBlanc, J. G., Matar, C., Valdéz, J. C., LeBlanc, J., & Perdigon, G. (2002) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(02)74360-9 · Cited by 210
Immunomodulating effects of whey proteins and their enzymatic digests.
Mercier, A., Gauthier, S. F., & Fliss, I. (2004) · International Dairy Journal · doi:10.1016/j.idairyj.2003.08.003 · Cited by 147 · cited 2×
“, by regulating the proliferation of lymphocytes and the production of different antibodies and cytokines [24-26].”
BackgroundThe isolation and bacteriostatic properties of lactoferrin from bovine milk whey
Law, B. A., & Reiter, B. (1977) · Journal of Dairy Research · doi:10.1017/s0022029900020550 · Cited by 139
MATAR, C., VALDEZ, J. C., MEDINA, M., RACHID, M., & PERDIGON, G. (2001) · Journal of Dairy Research · doi:10.1017/s0022029901005143 · Cited by 122
Matar, C., Nadathur, S. S., Bakalinsky, A. T., & Goulet, J. (1997) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(97)76139-3 · Cited by 69
Immunomodulatory activity of β-Casein permeate medium fermented by lactic acid bacteria.
Laffineur, E., Genetet, N., & Leonil, J. (1996) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(96)76585-2 · Cited by 56
Ueno, K., Mizuno, S., & Yamamoto, N. (2004) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2004.01560.x · Cited by 46 · cited 1×
“[118].”
Recombinant Human Lactoferrin Treatment for Global Health Issues: Iron Deficiency and Acute Diarrhea
Bethell, D. R., & Huang, J. (2004) · Biometals · doi:10.1023/b:biom.0000027714.56331.b8 · Cited by 40
Cited by
Sánchez, A., & Vázquez, A. (2017) · Food Quality and Safety · doi:10.1093/fqs/fyx006 · Cited by 868
“Some emerging technologies to recover BP from residual waste (Harnedy and Fitzgerald, 2012) and to transform them into addedvalue products, as well as to facilitate large-scale recovery (Kitts and Weiler, 2003; Agyei and Danquah, 2011) and purification of peptides aiming at future applications for the pharmaceutical (…”
BackgroundMethodMilk-derived bioactive peptides: From science to applications
Korhonen, H. (2009) · Journal of Functional Foods · doi:10.1016/j.jff.2009.01.007 · Cited by 700
Self-citationMilk derived bioactive peptides and their impact on human health – A review
Mohanty, D. P., Mohapatra, S., Misra, S., & Sahu, P. S. (2016) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2015.06.005 · Cited by 494
BIOACTIVE PROTEINS, PEPTIDES, AND AMINO ACIDS FROM MACROALGAE1: MACROALGAE: BIOACTIVE AGENT SOURCE
Harnedy, P. A., & FitzGerald, R. J. (2011) · Journal of Phycology · doi:10.1111/j.1529-8817.2011.00969.x · Cited by 393
Iwaniak, A., Minkiewicz, P., & Darewicz, M. (2014) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12051 · Cited by 318
Metadata
- Authors
- Korhonen, H., & Pihlanto, A.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-03-01
- Volume
- 13
- Issue
- 8
- Pages
- 829-843
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2064646355
- Cited by
- 230
- References
- 13
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.